发明名称 COMBINATIONS OF QUINOLINONE DERIVATIVES AND 5-FU OR CPT 11
摘要 Organic compounds having the formulas (I) and (II) are provided where the variables have the values described herein. Medicaments include an anti-cancer drug selected from 5-FU or CPT 11 and a compound of formula (I) or formula (II), a tautomer of the compound, a pharmaceutically acceptable salt of the compound, or a pharmaceutically acceptable salt of the tautomer in treatin along with an anti-cancer drug selected from 5-FU or CPT-11. The medicaments may be used in treating cancer. The use of a compound of formula (I) or formula (II), a tautomer of the compound, a pharmaceutically acceptable salt of the compound, or a pharmaceutically acceptable salt of the tautomer in treating cancer in conjunction with an anti-cancer drug selected from 5-FU or CPT-11 is also provided.
申请公布号 CA2481055(C) 申请公布日期 2011.02.01
申请号 CA20032481055 申请日期 2003.04.04
申请人 CHIRON CORPORATION 发明人 RENHOWE, PAUL A.;PECCHI, SABINA;MACHAJEWSKI, TIMOTHY D.;SHAFER, CYNTHIA M.;TAYLOR, CLARKE;MCCREA, WILLIAM R.;MCBRIDE, CHRISTOPHER;JAZAN, ELISA;HEISE, CARLA
分类号 A61K31/4709;C07D487/08;A61K31/19;A61K31/47;A61K31/4745;A61K31/496;A61K31/4995;A61K31/513;A61K31/5377;A61K31/541;A61P9/00;A61P35/00;A61P43/00;C07D401/04;C07D401/14;C07D405/04;C07D405/14;C07D409/04;C07D413/04;C07D413/14;C07D417/04;C07D453/02;C07D471/04;C07D519/00 主分类号 A61K31/4709
代理机构 代理人
主权项
地址